| Factor Information | |
|---|---|
| Data ID | 276 |
| Factor | PICU LOS |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | infants with CHD |
| p Value | <0.001 |
| Conclusion | The average PICU LOS and hospital LOS in the cyanotic group was significantly longer than the acyanotic group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 435 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | HRV/HLHS/SV/DILV/TAPVR/TOF/TOF, CAVC/CAVC/D-TGA, IVS/EA, w-PA/PS/Supracardiac TAPVR/Infracardiac TAPVR/Subaortic VSD w-PS/VSD/TA/TA/AS, CoA/CoA/PDA/VSD, HAA/DORV, PS |
| Reference | |
|---|---|
| PMID | 30430186 |
| Year | 2019 |
| Title | A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | infant | |
| Source | data | |
| Region | America, New York | |
| Method | comparison of post-operative variables | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | cardiac operation | |
| Group | Cyanotic CHD patients(Treatment) | Acyanotic CHD patients(Control) |
| Number | 17 | 24 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 18.0±22.0 days | 11.3±13.7 days |
